Lifitegrast

Xiidra

Lymphocyte Function-Associated Antigen-1 Antagonist

NADAC/unit $11.8386

No Shortage Tier 1: 16.4% PA Req: 12.8%

Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

vs. brand Xiidra: Generic saves up to -18% per unit

Covered Lives

Generic Manufacturers

BAUSCH AND LOMB INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Lifitegrast drfinder.aiFind doctors who prescribe Lifitegrast rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Lifitegrast

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.